Top Markets
Coin of the day
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.

TSHA
Pozycja w akcjach #6654
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and... Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.
Cena akcji
$6.02
Ostatnia synchronizacja: 2026-08-27
Kapitalizacja rynkowa
$1.93B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
112.72%
Kraj
US
Handel Taysha Gene Therapies, Inc. (TSHA)

Kategoria

Historia ceny akcji dla Taysha Gene Therapies, Inc. (TSHA)
Najwyższa cena zamknięcia: $6.22 dnia 2026-08-01

Najniższa cena zamknięcia: $23.52 dnia 2020-09-01
Historia cen akcji firmy Taysha Gene Therapies, Inc. od 2020 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -5.89%
2025 151.61%
2024 28.42%
2023 -21.84%
2022 -83.88%
2021 -42.11%
2020 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$548.36 39.87%
US
$1.06K 50.29%
NL
$122.42 -11.85%
AU
$140.81 475.44%
US
$765.25 7.74%
CH